» Articles » PMID: 12869193

Structure of the O-polysaccharide from Proteus Myxofaciens. Classification of the Bacterium into a New Proteus-O-serogroup

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 2003 Jul 19
PMID 12869193
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The O-polysaccharide (O-antigen) was obtained from the lipopolysaccharide of Proteus myxofaciens, a Proteus strain producing copious amounts of slime, which was isolated from the gypsy moth larvae. The structure of the polysaccharide was studied by chemical analysis and 1H and 13C NMR spectroscopy, including 2D COSY, TOCSY, ROESY and H-detected 1H,13C HMQC experiments. It was found that the polysaccharide contains an amide of glucuronic acid (GlcA) with an unusual alpha-linked amino acid, Nepsilon-[(R)-1-carboxyethyl]-l-lysine (2S,8R-alaninolysine, 2S,8R-AlaLys), and has a linear tetrasaccharide repeating unit of the following structure: This structure is unique among known bacterial polysaccharide structures. On the basis of these and serological data, it is proposed that P. myxofaciens be classified into a new Proteus serogroup, O60, of which this strain is the single representative. Structural and serological relatedness of P. myxofaciens to other AlaLys-containing O-antigens of Proteus and Providencia is discussed.

Citing Articles

The prevailing O serogroups among the serologically differentiated clinical Proteus spp. strains in central Poland.

Drzewiecka D, Palusiak A, Siwinska M, Zablotni A Sci Rep. 2021; 11(1):18982.

PMID: 34556711 PMC: 8460819. DOI: 10.1038/s41598-021-98228-w.


Molecular structure of endotoxins from Gram-negative marine bacteria: an update.

Leone S, Silipo A, Nazarenko E, Lanzetta R, Parrilli M, Molinaro A Mar Drugs. 2008; 5(3):85-112.

PMID: 18463721 PMC: 2365688. DOI: 10.3390/md503085.


Serological and structural characterization of the O-antigens of the unclassified Proteus mirabilis strains TG 83, TG 319, and CCUG 10700 (OA).

Zablotni A, Zych K, Kondakova A, Siwinska M, Knirel Y, Sidorczyk Z Arch Immunol Ther Exp (Warsz). 2008; 55(5):347-52.

PMID: 18219766 PMC: 2766449. DOI: 10.1007/s00005-007-0040-8.